Factors Associated With Increased Complications in Patients With BRCA Gene Mutations Undergoing Reconstructive Breast Surgery.
Autores de IIS La Fe
Abstract
Reconstructive breast surgery after bilateral prophylactic mastectomy in patients who carry a mutation of the breast cancer (BRCA) gene has been increasing. Undergoing risk-reducing breast surgery can be of great benefit to young patients who have a high risk of developing breast cancer. There is little available evidence about the rate of complications in these patients and which factors are related to increased complications. The objective of this study was to identify predictors of complications in BRCA gene mutation carriers who underwent reconstructive breast surgery. A single-center, retrospective cohort study was conducted that included all patients with a mutation of the BRCA gene who underwent a breast reconstructive procedure, either immediate or delayed, between January 2013 and March 2019 and received a minimum of 6 months' follow-up. The results of our study showed that smoking is the most important modifiable risk factor associated with an increased complication rate for reconstructive breast surgery in patients with BRCA gene mutation. Smoking cessation will reduce the patient's risk for postoperative complications by 50%; therefore, it should be encouraged in all surgical patients and enforced in patients undergoing prophylactic procedures.
Datos de la publicación
- ISSN/ISSNe:
- 0741-5206, 1550-1841
- Tipo:
- Article
- Páginas:
- 43-50
- Factor de Impacto:
- 0,149 SCImago ℠
- Cuartil:
- Q4 SCImago ℠
Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses Lippincott Williams & Wilkins Ltd.
Documentos
- No hay documentos
Filiaciones
Proyectos asociados
ESTUDIO PARA LA VALIDACIÓN DEL VALOR PRONÓSTICO DE LA CARGA TUMORAL TOTAL, DETERMINADO POR OSNA, DE LA METÁSTASIS EN EL GANGLIO CENTINELA DEL CÁNCER DE MAMA.
Investigador Principal: FRANCISCO RIPOLL ORTS
GES-2017-01 . 2018
CHAIMELEON. ACCELERATING THE LAB TO MARKET TRANSITION OF AI TOOLS FOR CANCER MANAGEMENT.
Investigador Principal: LUIS MARTÍ BONMATÍ
952172 . COMISION EUROPEA . 2020
ESTUDIO SOBRE LA CICATRIZACIÓN DE LA ZONA DONANTE DE INJERTO DE PIEL PARCIAL EN PACIENTES QUEMADOS TRAS APLICACIÓN DE PLASMA RICO EN PLAQUETAS O PLASMA RICO EN FACTORES DE CRECIMIENTO FRENTE A LA FORMA TERAPÉUTICA HABITUAL.
Investigador Principal: MARÍA DOLORES PÉREZ DEL CAZ
PRPZDSKIN . 2016
EL IMPACTO PRONÓSTICO DE LA NUTRICIÓN EN EL PACIENTE QUEMADO.
Investigador Principal: Mª NIEVES VANACLOCHA SAIZ
NUTRIBURN
EVALUACIÓN DE LA SEGURIDAD DE LA ESTIMULACIÓN OVÁRICA CONTROLADA COMO TÉCNICA DE PRESERVACIÓN DE LA FERTILIDAD EN PAC IENTES CON CÁNCER DE MAMA.
Investigador Principal: CÉSAR DÍAZ GARCÍA
ISF-LET-2019-01 . 2020
UTILIZACIÓN DE LA RADIOTERAPIA INTRAOPERATORIA EN LA NEOPLASIA DE MAMA.
Investigador Principal: FRANCISCO JAVIER CELADA ÁLVAREZ
SESPM-19-1 . 2021
Cita
Vanaclocha N,Ripoll F,Moreda ML,Sánchez A. Factors Associated With Increased Complications in Patients With BRCA Gene Mutations Undergoing Reconstructive Breast Surgery. Plast Surg Nurs. 2021. 41. (1):p. 43-50.